This resolution expresses the Senate's strong support for designating April 2025 as "Parkinson's Awareness Month" to highlight the significant impact of Parkinson's disease. It notes that over 1,000,000 individuals in the United States are affected, with nearly 90,000 new diagnoses annually, making it the fastest-growing and second most common neurodegenerative disease globally. The resolution emphasizes that by 2037, the number of individuals with Parkinson's is projected to nearly double, incurring an annual cost of at least $80 billion. The Senate supports the goals and ideals of Parkinson's Awareness Month, advocating for continued research to find better treatments and a cure for the disease. It recognizes the vital contributions of individuals living with Parkinson's who participate in clinical trials and commends the dedication of organizations, volunteers, and researchers working to improve the quality of life for patients and their families. This initiative seeks to foster greater understanding and support for those affected by this complex condition.